𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Androgen receptor binding activity in human prostate cancer

✍ Scribed by Ralph C. Benson Jr; David C. Utz; Eileen Holicky; Carlo M. Veneziale


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
730 KB
Volume
55
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Androgen receptor and caveolin-1 in pros
✍ Nigel Bennett; John D. Hooper; C. Soon Lee; Glenda C. Gobe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 243 KB

## Abstract The androgen receptor (AR) is involved in the development and maintenance of the normal prostate and the development and progression of prostate cancer (PCa). Caveolin‐1 (cav‐1) is an AR co‐regulator. The expression of this integral membrane protein is upregulated in PCa and correlates

Androgen receptor and caveolin-1 in pros
✍ Nigel Bennett; John D. Hooper; C. Soon Lee; Glenda C. Gobe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Abstract Flow diagram of androgen, androgen receptor and caveolin‐1 activity. See Androgen Receptor and Caveolin‐1 in Prostate Cancer by Bennett et al., pp. 961–970.

Androgen receptor gene mutations in horm
✍ WallοΏ½n, Mika J.; Linja, Marika; Kaartinen, Kaius; Schleutker, Johanna; Visakorpi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 2 views

Prostate cancer is considered to be one of the most hormone-dependent human malignancies. As a key mediator of hormonal response, the androgen receptor (AR) is believed to have an important role in the progression of prostate cancer. Mutations in the coding region of the AR gene have been found in b

Androgen axis in prostate cancer
✍ Zoran Culig; Georg Bartsch πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 156 KB

## Abstract Endocrine therapy for advanced prostate cancer is based on androgen ablation or blockade of the androgen receptor (AR). AR action in prostate cancer has been investigated in a number of cell lines, their derivatives, and transgenic animals. AR expression is heterogenous in prostate canc

Differential transactivation by the andr
✍ Snoek, Robert; Bruchovsky, Nicholas; Kasper, Susan; Matusik, Robert J.; Gleave, πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 232 KB πŸ‘ 2 views

## BACKGROUND. The purpose of this study was to determine the contribution of different transactivating regions of the androgen receptor (AR) to the induction of androgen-regulated promoters in poorly (PC3 cells) and well-differentiated (LNCaP cells) prostate cancer cell lines. METHODS. PC3 and LN